Brown Jeremiah R, Rezaee Michael E, Nichols Elizabeth L, Marshall Emily J, Siew Edward D, Matheny Michael E
The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Lebanon, NH Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH Department of Community and Family Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH
The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Lebanon, NH Oakland University William Beaumont School of Medicine, Rochester, MI.
J Am Heart Assoc. 2016 Mar 15;5(3):e002739. doi: 10.1161/JAHA.115.002739.
Acute kidney injury (AKI) and dialysis-requiring AKI (AKI-D) are common, serious complications of cardiac procedures.
We evaluated 3 633 762 (17 765 214 weighted population) cardiac catheterization or percutaneous coronary intervention (PCI) hospital discharges from the nationally representative National Inpatient Sample to determine annual population incidence rates for AKI and AKI-D in the United States from 2001 to 2011. Odds ratios for both conditions and associated in-hospital mortality were calculated for each year in the study period using multiple logistic regression. The number of cardiac catheterization or PCI cases resulting in AKI rose almost 3-fold from 2001 to 2011. The adjusted odds of AKI and AKI-D per year among cardiac catheterization and PCI patients were 1.11 (95% CI: 1.10-1.12) and 1.01 (95% CI: 0.99-1.02), respectively. Most importantly, in-hospital mortality significantly decreased from 2001 to 2011 for AKI (19.6-9.2%) and AKI-D (28.3-19.9%), whereas odds of associated in-hospital mortality were 0.50 (95% CI: 0.45-0.56) and 0.70 (95% CI: 0.55-0.93) in 2011 versus 2001, respectively. The population-attributable risk of mortality for AKI and AKI-D was 25.8% and 3.8% in 2001 and 41.1% and 6.5% in 2011, respectively. Males and females had similar patterns of AKI increase, although males outpaced females.
The Incidence of AKI among cardiac catheterization and PCI patients has increased sharply in the United States, and this should be addressed by implementing prevention strategies. However, mortality has significantly declined, suggesting that efforts to manage AKI and AKI-D after cardiac catheterization and PCI have reduced mortality.
急性肾损伤(AKI)以及需要透析的急性肾损伤(AKI-D)是心脏手术常见且严重的并发症。
我们评估了来自具有全国代表性的国家住院患者样本中的3633762例(加权人口为17765214)心脏导管插入术或经皮冠状动脉介入治疗(PCI)的出院病例,以确定2001年至2011年美国AKI和AKI-D的年度人口发病率。在研究期间,每年使用多因素逻辑回归计算这两种情况的比值比以及相关的院内死亡率。从2001年到2011年,导致AKI的心脏导管插入术或PCI病例数增加了近3倍。心脏导管插入术和PCI患者每年发生AKI和AKI-D的校正比值分别为1.11(95%CI:1.10-1.12)和1.01(95%CI:0.99-1.02)。最重要的是,2001年至2011年期间,AKI(从19.6%降至9.2%)和AKI-D(从28.3%降至19.9%)的院内死亡率显著下降,而2011年与2001年相比,相关院内死亡的比值分别为0.50(95%CI:0.45-0.56)和0.70(95%CI:0.55-0.93)。2001年AKI和AKI-D的人群归因死亡风险分别为25.8%和3.8%,2011年分别为41.1%和6.5%。男性和女性的AKI增加模式相似,尽管男性增速超过女性。
在美国,心脏导管插入术和PCI患者中AKI的发病率急剧上升,应通过实施预防策略来解决这一问题。然而,死亡率显著下降,这表明在心脏导管插入术和PCI后对AKI和AKI-D的管理努力降低了死亡率。